The Chandan Healthcare IPO Price Target 2030 is scheduled to open on February 10, 2025, and close on February 12, 2025, with the expected listing date on February 17, 2025. The IPO price range is ₹151 to ₹159 per share, with a total issue size of ₹107.36 crores. The company will be listed on the NSE SME exchange, and the minimum lot size for retail investors is 800 shares.
IPO Details
- IPO Opening Date: February 10, 2025
- IPO Closing Date: February 12, 2025
- Listing Date: February 17, 2025
- Issue Price: ₹151 to ₹159 per share
- Total Issue Size: ₹107.36 crores
- Lot Size: 800 shares
- Exchange: NSE SME
Company Background
Chandan Healthcare Limited is a healthcare and diagnostic service provider, specializing in pathology, radiology, and other diagnostic services. The company has a strong presence in Northern India, focusing on expanding its network of diagnostic centers and healthcare services.
Objectives of the IPO
- Expansion of Diagnostic Centers – Opening new centers to enhance service accessibility.
- Upgrading Medical Equipment – Investing in advanced diagnostic technology.
- Working Capital Requirements – Strengthening financial flexibility.
- General Corporate Purposes – Supporting overall business operations and growth.
Financial Performance & Share Price Predictions
- Revenue (Last FY): ₹250 Crores
- Profit (Last FY): ₹35 Crores
- Year-over-Year Growth: 18%
| Year | Predicted Share Price (₹) |
|---|---|
| 2025 | ₹165 – ₹185 |
| 2026 | ₹190 – ₹215 |
| 2027 | ₹230 – ₹260 |
| 2028 | ₹270 – ₹300 |
| 2029 | ₹310 – ₹340 |
| 2030 | ₹350 – ₹380 |
Subscription & Grey Market Premium (GMP) Details
| Category | Expected Subscription |
|---|---|
| Retail Investors | High |
| Institutional Investors | Moderate |
| HNIs | Strong |
- GMP for Chandan Healthcare Limited: ₹[To be updated closer to listing]
Key Growth Factors
- Rising Demand for Healthcare Services – Growing need for diagnostic and pathology services.
- Government Healthcare Initiatives – Policies promoting affordable medical testing.
- Technological Advancements – Investment in AI-based diagnostics and automation.
- Expansion in Tier 2 & Tier 3 Cities – Increasing healthcare access beyond metro cities.
Conclusion: Is Chandan Healthcare Limited a Good Investment?
The Chandan Healthcare Limited IPO offers an opportunity to invest in a growing healthcare diagnostics company. With expansion plans, strong financials, and a rising healthcare market, the company is well-positioned for long-term growth. However, investors should evaluate market trends and IPO performance before investing.